ALS, also known as Lou Gehrigs disease, causes death within a few years and desperately needs a strong treatment. 이 약이 미국 식품의약국의 승인을 통과한다면 블록버스터가 될 수 있습니다. Dexpramipexole joins a cavalcade of failed ALS treatments over the years.